The Future of the FDA: Operating in an Electronic World

Acording to an Axendia reseach study, the FDA is currently shifting its organizational and technology infrastructures to facilitate electronic interactions with the companies it regulates. 
The results of the research conducted by Axendia Inc, commissioned by MasterControl to research FDA’s movement to electronic interactions, includes interviews with key FDA officials that identify major transformational activities that:

  • Promise to usher in a new era of electronic interactions between the FDA and its constituents
  • Move towards working in an environment where all regulated product information comes in electronically, whether it be product quality, manufacturing, pre-market, or post market data
  • And much, much more

Download White Paper